Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Carsten Spanka

Carsten Spanka, Basel CH

Patent application numberDescriptionPublished
200902644063-METHYL-IMIDAZO[1,2-B]PYRIDAZINE DERIVATIVES - The invention relates to compounds of formula (I) and salts thereof10-22-2009
20110009429HETEROCYCLIC COMPOUNDS AS INHIBITORS OF CXCR2 - The present invention relates to compounds of formula (I)01-13-2011

Carsten Spanka, Lorrach DE

Patent application numberDescriptionPublished
20080242698Organic Compounds - The invention relates to novel diamines of the formula10-02-2008
20090005363Organic Compounds - The present invention relates to novel nicotinic acid derivatives, of formula (I)01-01-2009
20090137804Compounds and Compositions as Protein Kinase Inhibitors - The invention relates to compounds of formula (I)05-28-2009
20090286827NOVEL BI-ARYL AMINES - The present invention relates to novel bi-aryl amines of formula (I) and to pharmaceutically acceptable prodrugs, salts, solvates, hydrates, and N-oxides thereof and to pharmaceutical compositions comprising them, methods of their use, and methods of their preparation.11-19-2009
20100069407CXCR2 inhibitors - The present invention relates to compounds of formula (I) and the use of these compounds as pharmaceuticals, e.g. in preventing or treating a CXCR2 receptor mediated condition or disease.03-18-2010
20100152205CXCR2 INHIBITORS - The present invention relates to compounds of formula (I) and the use of these compounds as pharmaceuticals, e.g. in preventing or treating a CXCR2 receptor mediated condition or disease.06-17-2010

Patent applications by Carsten Spanka, Lorrach DE

Carsten Spanka, Loerrach DE

Patent application numberDescriptionPublished
20110243923ORGANIC COMPOUNDS - The present invention relates to modulators of the interaction between Epstein-Barr Virus induced receptor-2 (EBi2) and cholest-5-ene-3b,7b,25-triol (7, 25-dihydroxycholesterol) (“7,25DHC”) and/or cholest-5-ene-3b, 7b-diol (7-hydroxycholesterol) (“7HC”). The modulator maybe a small chemical molecule, antibody or other therapeutic protein. Methods of medical treatment and methods of identifying modulators are also described.10-06-2011